Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - In: Journal of benefit-cost analysis : JBCA 13 (2022) 2, pp. 166-181
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper … examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost … quality-adjusted life years (QALYs) and incremental pharmaceutical costs. The preferred sample uses 476 studies involving …